作者：
Eisen,T. [1]
;
Joensuu,H. [2]
;
Nathan,P.D. [3]
;
Harper,P.G. [4]
;
Wojtukiewicz,M.Z. [5]
;
Nicholson,S. [6]
;
Bahl,A. [7]
;
Tomczak,P. [8]
;
Pyrhonen,S. [9]
;
Fife,K. [10]
;
Bono,P. [11]
;
Boxall,J. [12]
;
Wagner,A. ;
Jeffers,M. ;
Lin,T. ;
Quinn,D.I.
作者单位：
University Hospitals of Leicester, Leicester, United Kingdom
[1]
Uniwersytet Medyczny w Bia?ymstoku, Bia?ostockie Centrum onkologii, Bia?ystok, Poland
[2]
Bayer HealthCare Pharmaceuticals, Montville, NJ, United States
[3]
Bayer Pharma AG, Berlin, Germany
[4]
University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, United
[5]
Guy's Hospital, London, United Kingdom
[6]
Szpital Kliniczny Przemienienia Pańskiego UM, Klinika Onkologii, Poznan, Poland
[7]
Helsinki University Central Hospital, Helsinki, Finland
[8]
Mount Vernon Hospital, Northwood, United Kingdom
[9]
Bristol Haematology and Oncology Centre, Bristol, United Kingdom
[10]
Cambridge University Health Partners, Cambridge, United Kingdom
[11]
Turku University Hospital, Turku, Finland
[12]
发布时间
2013-11-20
换一批
